ArticleJHLT open2025
Does race influence health-related quality of life outcomes in older patients who undergo advanced cardiac surgical therapies?
Article in JHLT open, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper, 1 of them a synthesis that pooled it.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
1 citing paper in PubMed, 1 synthesis or guideline pooled it.
- A systematic review of the relationship between race and health-related quality of life outcomes in patients with advanced heart failure who undergo heart transplantation or mechanical circulatory support.Quality of life research : an international journal of quality of life aspects of treatment, care and rehabilitation · 2026Pooled it
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
6 authors.
Funding
Abstract
Background: Racial minorities are disproportionately affected by heart failure (HF). We aimed to determine whether (1) older patients (60-80 years) with HF who underwent long-term mechanical circulatory support (MCS, i.e., destination therapy), compared to patients who underwent heart transplantation (HT), with (HT MCS) or without (HT non-MCS) pretransplant MCS, experienced noninferior change in overall health-related quality of life (HRQOL) by race (White vs racial minorities) from baseline to 1-year postoperatively and (2) race was a risk factor associated with overall HRQOL at 1-year postoperatively. Methods: Patients were recruited from 13 US medical centers ( Results: The cohort's average age was 66 years, 78% were male, and 84% were White. The long-term MCS racial minority group did not demonstrate NI compared to the HT MCS and HT non-MCS racial minority groups, and the White long-term MCS group did not demonstrate NI compared to the White HT MCS and HT non-MCS groups. Sex (male) and surgical strategies (HT MCS and HT non-MCS) were positively associated with the KCCQ-12 OSS, whereas the number of postoperative adverse events was negatively associated. Conclusions: Patients experienced improved HRQOL after surgery, regardless of race; demographic and clinical factors were associated with HRQOL.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.